Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Hosp Infect ; 58(4): 268-75, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15617231

ABSTRACT

The aim of this study was to evaluate the number of deaths associated with nosocomial infections (NI) and the contribution of these NI to death. A multicentre descriptive study was conducted in 16 tertiary-care hospitals (14 222 beds) in Northern France. Medical records of consecutive patients who died at least 48 h after admission were reviewed for cause of death, NI and disease severity, before admission and before NI onset. The contribution of NI to death was assessed by agreement between two physicians according to a three-category scale of probability. Among the 1945 patients who died during the study, 26.6% had an NI. According to the agreed diagnosis, NI contributed to the deaths of 284 (14.6%) patients(certainly for 6.6% and possibly for 8%), thereby ranking NI as the fourth most frequent cause of death. Considering the deaths that had not been anticipated independently of NI two weeks before they occurred, NI definitely contributed to 2.8% of them. Lower respiratory tract, bloodstream and surgical wound infections were responsible for 39, 20 and 14%, respectively,of all NI in these patients. The impact of NI on in-hospital mortality seems to be lower than had previously been estimated in France based on US data from the 1970s and 1980s. To improve healthcare quality, further studies are needed to elucidate the processes that may contribute to fatal severe NI.


Subject(s)
Cross Infection/mortality , Hospital Mortality , Adolescent , Adult , Aged , Aged, 80 and over , Cause of Death , Child , Child, Preschool , Cross Infection/epidemiology , Female , France/epidemiology , Humans , Infant , Infant, Newborn , Male , Middle Aged , Prospective Studies
2.
Infect Control Hosp Epidemiol ; 20(5): 347-9, 1999 May.
Article in English | MEDLINE | ID: mdl-10349954

ABSTRACT

This prospective study was conducted to evaluate the risk of nosocomial pneumonia when changing heat and moisture exchangers every 48 hours in 1996 instead of every 24 hours in 1995 for patients needing continuous mechanical ventilation. Medical and surgical patients in the two periods did not differ in terms of demographic characteristics and markers of acute or underlying illnesses. The incidence density of nosocomial pneumonia was not different in the two groups. Extended heat and moisture exchanger use reduces circuit manipulation and cost.


Subject(s)
Critical Care/standards , Cross Infection/prevention & control , Disposable Equipment , Infection Control/standards , Pneumonia/prevention & control , Ventilators, Mechanical/adverse effects , Adult , Chi-Square Distribution , Confidence Intervals , Cross Infection/etiology , Disposable Equipment/economics , Female , Humans , Infection Control/economics , Male , Middle Aged , Odds Ratio , Pneumonia/etiology , Prospective Studies , Time Factors , Treatment Outcome , Ventilators, Mechanical/economics
3.
Pathol Biol (Paris) ; 46(6): 470-5, 1998 Jun.
Article in French | MEDLINE | ID: mdl-9769884

ABSTRACT

A six-month prospective study of costs associated with antimicrobial therapy in nosocomial bacteremia was conducted from November 1, 1995 to April 30, 1996 in a 1837-bed teaching hospital, with the help of the hospital pharmacists and hospital hygiene unit. Only the costs due to the antimicrobials themselves were taken into account. A total of 238 cases of nosocomial bacteremia occurred during the study period. The total direct cost of antimicrobial therapy was 444,931 French francs (FF), i.e., 6.8% of total expenditures for antimicrobials. Mean cost per case was 1869 FF, and was 2.6-fold higher in the 21 patients with bacteremia due to more than one organism (P = 0.03). CAses with an identifiable portal of entry contributed 75% of the total cost. Portals of entry associated with the highest cost included central venous lines (103,928 FF) and urinary tract infections (50,810 FF). Although 20% of nosocomial bacteremias due to coagulase-negative staphylococci did not lead to antimicrobial therapy, the remaining 80% contributed 40.8% of the total cost, followed by nosocomial bacteremias due to Escherichia coli with 19.7% of the total cost. Thirty-seven patients (15.5%) did not receive specific antimicrobial therapy, for the following reasons: death before treatment initiation, transfer to another hospital, antimicrobial therapy initiated earlier for another infection elsewhere in the body due to a different organism, or other form of treatment. The results of this study highlight the need for prevention.


Subject(s)
Anti-Bacterial Agents/economics , Bacteremia/economics , Cross Infection/economics , Drug Costs , Hospital Costs , Hospitals, University/economics , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/etiology , Bacteremia/microbiology , Catheterization, Central Venous/adverse effects , Cross Infection/drug therapy , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/economics , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/economics , Hospitals, University/statistics & numerical data , Humans , Prospective Studies , Urinary Tract Infections/complications , Urinary Tract Infections/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...